SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a ...
Please provide your email address to receive an email when new articles are posted on . Health information technology (HIT) use by patients with COPD was incrementally associated with pneumococcal ...
This technology is now being taken forward commercially through the recently formed spin-out company PulmonIR Ltd. Clinical trials in collaboration with Cwm Taf University Health Board to validate the ...
Hosted on MSN
Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma
Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval from China’s National Medical Products Administration/NMPA for Yupelri ...
Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum ...
Biosency SA's Bora Care remote monitoring solution can predict acute chronic obstructive pulmonary disease (COPD) exacerbations on average three days prior to hospitalization, according to initial ...
Mount Sinai Hospital in New York City is testing an app to track chronic obstructive pulmonary disorder patients’ symptoms, medication, treatment adherence and quality of life. The app, called COPD ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. This is something I'm particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results